Table 1.
Malignancies in the p53+/- irradiation model.
No. | p53 geno-type | WASp genotype | Death after irradiation (weeks) | Histology | Macro-scopically ulcerating | Spleno-megaly | Tumor infiltration of CD45+ (FACS) |
---|---|---|---|---|---|---|---|
A) Spindle cell tumors | |||||||
46B | +/- | + | 9 | Cystic hair follicle dilatation with large numbers of F4/80+ spindle shaped atypical cells in surrounding dermis | NO | YES | N/A |
89C | +/- | + | 13 | Spindle tumor, malignant, NOS; up to 8 mit/40x. Ulcerated. Extensive F4/80 positivity in spindle cell tumor area. | YES | NO | low myeloid |
135A | +/- | + | 24 | Spindle tumor, malignant, NOS; up to 10 mit/40x. Ulcerated. Extensive F4/80 positivity in spindle cell tumor area. | YES | YES | N/A |
87A | +/- | - | 6 | Spindle tumor, malignant, NOS. Neutrophils are present in the necrotic area, but the tum. is not heavily infiltrated. | YES | YES | high myeloid |
89A | +/- | - | 8 | Subcut. abcess overlying lymphnode. Marked F4/80+ spindle cell proliferation in surroundings, neovascularisation. Neutrophils are associated with the abscess with puss. | NO | YES | high myeloid SP,BL: CD11b exp. |
83B | +/- | XLN (I296T) | 22 | Spindle tumor, malignant, NOS; up to 6 mit/40x. Ulcerated. Extensive F4/80 positivity in spindle cell tumor area. Neutrophils are abundant in the tumor mass even far from the ulceration. | NO | YES | low myeloid+ |
105C | +/- | XLN (L272P) | 13 | Spindle tumor, malignant, NOS; up to 5 mit/40x. Extensive F4/80 positivity in spindle cell tumor area. Neutrophils are rare and they are not appear to be the integral part of tumor mass. | NO | NO | Low SP: CD11b exp. |
49B |
+/+ |
+ |
23 |
Spindle tumor, malignant, NOS; up to 5 mit/40x. Extensive F4/80 positivity in spindle cell tumor area. |
NO |
NO |
N/A |
No. |
p53 geno-type |
WASp genotype |
Death after irradiation (weeks) |
Histology |
Enlargedthymus |
Spleno-megaly |
Hematopoietic infiltration (FACS) |
B) Lymphomas | |||||||
119A | +/- | + | 24 | N/A | YES | YES | |
123A | +/- | + | 9 | Neoplastic, lymhoid infiltr. of BM,LN,SPL, liver and lung | NO | YES | LIV: High T cell infiltr. BL: T norm, B lymphopeina |
124A | +/- | + | 12 | Hematopoietic neoplasm | NO | YES | LIV: T cell SP,BL: T cell exp. |
78A | +/- | - | 24 | Lymphoma | YES | YES | LIV: T cell exp. |
118A | +/- | - | 22 | Lymphoma | YES | NO | LIV: T cell exp. SP:CD34+ exp. |
65B | +/- | XLN(I296T) | 18 | High grade lymphoblastic lymphoma | YES | YES | |
84B | +/- | XLN(I296T) | 20 | N/A | YES | N/A | |
101C |
+/- |
XLN(L272P) |
18 |
N/A |
YES |
NO |
|
No. |
p53 geno-type |
WASp genotype |
Death after irradiation (weeks) |
Histology |
Cause of death |
Spleno-megaly |
Hematopoietic infiltration (FACS) |
C) Mixed hematopoietic proliferation | |||||||
44C | +/- | + | 15 | LIV: enlarged, white dotted LIV, SP, BM: hematopietic expansion LIV: Large numbers of F4/80+ cells Disseminated histiocytic neoplasm? | Severe weightloss | YES | LIV: T cell (CD3+) and myeloid (CD11b+) infiltration SP: T,B compartments are replaced by lin-(CD3-CD19-CD11b-) cells BL: T,B lymphopenia |
117C | +/- | + | 24 | Pre-neoplastic? SP,BM: myeloid proliferation | EP | YES | LIV: T cell (CD3+) and myeloid (CD11b+) infiltration SP: norm. |
111A | +/- | - | 24 | Pre-neoplastic? SP,LIV: mixed proliferation of hematopoietic components, probably lymphocytes and macrophages. SP,BM: myeloid proliferation | EP | YES | Myeloid infiltraton in liver SP: T,B compartments are replaced by lin-(CD3-CD19-CD11b-) cells |
114A |
+/- |
- |
10 |
LIV, LN: mainly lymphopblastic proliferation with myeloid components |
Severe weightloss |
YES |
LIV (pale col.): High myeloid (CD11b+) expansion. T,B exp. SP: T,B compartments are replaced by lin-(CD3-CD19-CD11b-) cells BL (pale color): very high myeloid counts, T,B lymphopenia |
No. |
p53 geno-type |
WASp genotype |
Death after irradiation (weeks) |
Histology |
Cause of death |
Spleno-megaly |
Hematopoietic infiltration (FACS) |
D) Unknown | |||||||
101A | +/- | - | 18 | Large abscess on skin; reactive expansion of myeloid lineage? | Prolif. | YES | |
153A | +/- | - | 5 | N/A | Severe weightloss | N/A |